The Clinical Application of Serum Squamous Cell Carcinoma Antigen Level Monitoring in Invasive Cervical Carcinoma

By Maiman M.  

Gynecologic Oncology, Vol. 84, Iss. 1, 2002-01 ,pp. : 4-6

Elsevier

Access to resources Recommend Favorite

Improvement of Clinical Staging in Cervical Cancer with Serum Squamous Cell Carcinoma Antigen and CA 125 Determinations

By Massuger L.F.A.G.   Koper N.P.   Thomas C.M.G.   Dom K.E.L.   Schijf C.P.T.  

Gynecologic Oncology, Vol. 64, Iss. 3, 1997-03 ,pp. : 473-476

Elsevier

Access to resources Recommend Favorite

The Value of Squamous Cell Carcinoma Antigen as a Predictor of Nodal Metastasis in Cervical Cancer

By Takeshima N.   Hirai Y.   Katase K.   Yano K.   Yamauchi K.   Hasumi K.  

Gynecologic Oncology, Vol. 68, Iss. 3, 1998-03 ,pp. : 263-266

Elsevier

Access to resources Recommend Favorite

Can Initial Serum Cyfra 21-1, SCC Antigen, and TPA Levels in Squamous Cell Cervical Cancer Predict Lymph Node Metastases or Prognosis?

By Gaarenstroom K.N.   Kenter G.G.   Bonfrer J.M.G.   Korse C.M.   Van de Vijver M.J.   Fleuren G.-J.   Trimbos J.B.  

Gynecologic Oncology, Vol. 77, Iss. 1, 2000-04 ,pp. : 164-170

Elsevier

Access to resources Recommend Favorite

Risk factors for progression of squamous cell cervical carcinoma in-situ to invasive cervical cancer: results of a multinational study

By Thomas D.B.   Ray R.M.   Qin Q.  

Cancer Causes and Control, Vol. 13, Iss. 7, 2002-09 ,pp. : 683-690

Springer Publishing Company

Access to resources Recommend Favorite